BIOCAPTIVA to conduct ex-vivo study to evaluate the potential of the BioCaptis device to capture cell free DNA to improve pleural disease diagnosis Study aims to establish whether BioCaptis technology can be used to isolate cell free DNA (cfDNA) from pleural fluid samples in sufficient quantities for downstream DNA analysisGoal is to identify...